Literature DB >> 15634280

A novel mechanism of plasmin-induced mitogenesis in fibroblasts.

S K Mandal1, L V M Rao, T T T Tran, U R Pendurthi.   

Abstract

The plasminogen activator/plasmin system is believed to play an important role in diverse pathophysiological processes, including wound healing, vascular remodeling and pulmonary fibrosis. Our recent studies show that plasmin upregulates the expression of Cyr61, a growth factor-like gene that has been implicated in cell proliferation and migration. In the present study, we investigated whether plasmin promotes fibroblast proliferation and, if so, determine the role of Cyr61 in the plasmin-induced response. Human lung fibroblasts were exposed to varying concentrations of plasmin and DNA synthesis was monitored by measuring the incorporation of 3H-thymidine into DNA. Plasmin increased DNA synthesis of fibroblasts in a dose-dependent manner. Protease-activated receptor-1 (PAR-1)-specific antibodies, but not PAR-2-specific antibodies, reduced the plasmin-induced DNA synthesis. Consistent with this, plasmin had no substantial effect on the DNA synthesis in PAR-1-deficient mouse fibroblasts. Plasmin activated both p38 and p44/42 MAPKs and specific inhibitors of these pathways inhibited the plasmin-induced DNA synthesis. Plasmin-induced increase in the DNA synthesis was completely abrogated by anti-Cyr61 antibodies. Interestingly, thrombin, which is a potent inducer of Cyr61, had only a minimal effect on fibroblast proliferation. Additional experiments suggested that plasmin cleaved cell/extracellular matrix-associated Cyr61 and the conditioned media from plasmin-treated cells could support the cell proliferation. Overall, these data suggest that plasmin promotes fibroblast proliferation by a novel pathway, involving two independent steps. In the first step, plasmin induces Cyr61 expression via activation of PAR-1, and in the second step, plasmin releases Cyr61 deposited in the extracellular matrix, thus making it accessible to act on cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634280      PMCID: PMC2829869          DOI: 10.1111/j.1538-7836.2004.01054.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  36 in total

1.  Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway.

Authors:  Usha R Pendurthi; Mylinh Ngyuen; Patricia Andrade-Gordon; Lars C Petersen; L Vijaya Mohan Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

2.  Proliferation of a human epidermal tumor cell line stimulated by urokinase.

Authors:  J C Kirchheimer; J Wojta; G Christ; B R Binder
Journal:  FASEB J       Date:  1987-08       Impact factor: 5.191

Review 3.  Gene targeting of components of the fibrinolytic system.

Authors:  Victoria A Ploplis; Francis J Castellino
Journal:  Thromb Haemost       Date:  2002-01       Impact factor: 5.249

4.  Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture.

Authors:  Makoto Akao; Yuichi Hasebe; Nobuaki Okumura; Hiromi Hagiwara; Taiichiro Seki; Toyohiko Ariga
Journal:  Thromb Res       Date:  2002-08-15       Impact factor: 3.944

5.  Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction.

Authors:  U R Pendurthi; K E Allen; M Ezban; L V Rao
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

6.  Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.

Authors:  D Loew; C Perrault; M Morales; S Moog; C Ravanat; S Schuhler; R Arcone; C Pietropaolo; J P Cazenave; A van Dorsselaer; F Lanza
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

7.  Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.

Authors:  A I Schafer; A K Maas; J A Ware; P C Johnson; S E Rittenhouse; E W Salzman
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

8.  CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.

Authors:  T M Grzeszkiewicz; D J Kirschling; N Chen; L F Lau
Journal:  J Biol Chem       Date:  2001-04-03       Impact factor: 5.157

9.  Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.

Authors:  Rosemarijn Renckens; Sebastiaan Weijer; Alex F de Vos; Jennie M Pater; Joost C Meijers; C Erik Hack; Marcel Levi; Tom van der Poll
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

Review 10.  Specificity of coagulation factor signaling.

Authors:  W Ruf; A Dorfleutner; M Riewald
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

View more
  13 in total

1.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.

Authors:  Christopher S Gondi; Neelima Kandhukuri; Shakuntala Kondraganti; Meena Gujrati; William C Olivero; Dzung H Dinh; Jasti S Rao
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

Review 3.  Tissue factor-factor VIIa signaling.

Authors:  L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-29       Impact factor: 8.311

4.  Proteolysis of CCN1 by plasmin: functional implications.

Authors:  Usha R Pendurthi; Tien T Tran; Marina Post; L Vijaya Mohan Rao
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

5.  Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors.

Authors:  Luqiang Wang; Lutian Yao; Hao Duan; Fan Yang; Maohuan Lin; Rongxin Zhang; Zhenqiang He; Jaimo Ahn; Yi Fan; Ling Qin; Yanqing Gong
Journal:  J Bone Miner Res       Date:  2021-09-08       Impact factor: 6.741

6.  A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.

Authors:  Nobuaki Okumura; Tomohiko Koh; Yuichi Hasebe; Taiichiro Seki; Toyohiko Ariga
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

7.  The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.

Authors:  Torry A Tucker; Candice Dean; Andrey A Komissarov; Kathy Koenig; Andrew P Mazar; Usha Pendurthi; Timothy Allen; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-27       Impact factor: 6.914

8.  Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.

Authors:  Jeffrey C Horowitz; David S Rogers; Richard H Simon; Thomas H Sisson; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-26       Impact factor: 6.914

Review 9.  α-Enolase, a multifunctional protein: its role on pathophysiological situations.

Authors:  Angels Díaz-Ramos; Anna Roig-Borrellas; Ana García-Melero; Roser López-Alemany
Journal:  J Biomed Biotechnol       Date:  2012-10-14

Review 10.  Cell surface remodeling by plasmin: a new function for an old enzyme.

Authors:  Elena I Deryugina; James P Quigley
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.